Jin Wook (miles) Suk - 13 Nov 2024 Form 4/A - Amendment Insider Report for Abpro Holdings, Inc. (ABP)

Reporting relationship: Co-CEO & Chairman, Director
Issuer ticker: ABP
Reported as of: 13 Nov 2024
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 25 Nov 2024, 21:58:57 UTC
Original report date: 15 Nov 2024
Next SEC filing: 25 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact

Key filing fact

Jin Wook (miles) Suk filed Form 4/A - Amendment for Abpro Holdings, Inc. (ABP) on 25 Nov 2024.

Key facts

This page summarizes Jin Wook (miles) Suk's Form 4/A - Amendment filing for Abpro Holdings, Inc. (ABP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Nov 2024, 21:58.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ABP transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +613,500
Change %
Price: $0.000000
Shares after: 613,500
Date: 13 Nov 2024
Ownership: By Biocelsus International Co. Ltd.
Underlying class: Common Stock, par value $0.0001 per share
Underlying amount: 613,500
Exercise price: $1.63
Footnotes: F1, F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On November 15, 2024, the reporting person filed a Form 4 which inadvertently omitted the transaction disclosed hereby.

Footnote F2

Reflects the issuance by Abpro Holdings, Inc. (f/k/a Atlantic Coastal Acquisition Corp. II) (the "Issuer") on November 13, 2024, of rollover stock option awards in connection with the business combination between the Issuer and Abpro Corporation, a Delaware corporation ("Abpro"), pursuant to a Business Combination Agreement, dated as of December 11, 2023 (as amended by Amendment No. 1 to Business Combination Agreement, dated September 4, 2024, the "Business Combination Agreement"), by and among the Issuer, Abpro Merger Sub Corp, a Delaware corporation, and Abpro.

Footnote F3

This stock option award is 100% vested.

Footnote F4

Biocelsus International Co. Ltd. is controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.